This study investigated the efficacy and tolerability of adjunctive extended-release quetiapine fumarate ( quetiapine XR ) in patients with GAD and an inadequate response to selective serotonin reuptake inhibitors ( SSRIs ) and serotonin-norepinephrine reuptake inhibitors ( SNRIs ) .